DSIP for alcohol and opioid withdrawal: what an early study tells us
Study model: Humans; clinical report on 107 hospitalized patients
The research question
Withdrawal symptoms and long-term recovery are different outcomes. An early study of DSIP for alcohol and opioid withdrawal focused on symptoms during hospitalization.
What was found?
The publication describes 107 patients: 47 with alcohol withdrawal and 60 with opioid withdrawal. Doctors and nurses assessed the course. Not all patients could be evaluated. Favorable clinical observations were reported, but this report does not provide a robust randomized comparison that can establish the separate effect of DSIP.
What does this evidence mean?
Improvement during hospitalization may also be related to other care and the natural course of the condition. The study does not prove that DSIP prevents relapse or cures addiction. The older, potentially overlapping report with PMID 6328354 is not counted here as independent additional evidence.
Primary source
Research information, not medical advice. The described study does not establish safe use of an investigational product. Image: AI illustration, not a participant or a photograph from the study.
Related research products
View product specifications and available batch documentation. The studies discussed were not conducted with Peptidera products and do not prove the efficacy of our products. For laboratory research only; not for human or animal consumption.